73
Views
21
CrossRef citations to date
0
Altmetric
Original Research

Medical resource utilization and costs associated with autosomal dominant polycystic kidney disease in the USA: a retrospective matched cohort analysis of private insurer data

, , , , &
Pages 123-132 | Published online: 20 Feb 2015

References

  • TorresVEHarrisPCPirsonYAutosomal dominant polycystic kidney diseaseLancet20073691287130117434405
  • ZhouJPeiYAutosomal dominant polycystic kidney diseaseMountDBPollackMRMolecular and Genetic Basis of Renal Disease: A Companion to Brenner and Rector’s The KidneyPhiladelphia, PA, USASaunders Elsevier2008
  • GranthamJJChapmanABTorresVEVolume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomesClin J Am Soc Nephrol2006114815717699202
  • GabowPAAutosomal dominant polycystic kidney diseaseAm J Kidney Dis1993225115128213788
  • TaylorMJohnsonAMTisonMFainPSchrierRWEarlier diagnosis of autosomal dominant polycystic kidney disease: importance of family history and implications for cardiovascular and renal complicationsAm J Kidney Dis20054641542316129202
  • US Renal Data SystemUSRDS 2012 annual data report: atlas of chronic kidney disease and end-stage renal disease in the United StatesBethesda, MD, USANational Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases2012 Available from: http://www.ajkd.org/issue/S0272-6386%2812%29X0003-9Accessed December 4, 2014
  • SchrierRMcFannKJohnsonACardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized studyJ Am Soc Nephrol2002131733173912089368
  • MaschioGAlbertiDJaninGEffect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study GroupN Engl J Med19963349399458596594
  • KlahrSBreyerJABeckGJDietary protein restriction, blood pressure control, and the progression of polycystic kidney disease. Modification of Diet in Renal Disease Study GroupJ Am Soc Nephrol19955203720477579052
  • LentineKLXiaoHMachnickiGGheorghianASchnitzlerMARenal function and healthcare costs in patients with polycystic kidney diseaseClin J Am Soc Nephrol201051471147920538839
  • ChapmanABJohnsonAMGabowPAPregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney diseaseJ Am Soc Nephrol19945117811857873727
  • RuleADTorresVEChapmanABCRISP ConsortiumComparison of methods for determining renal function decline in early autosomal dominant polycystic kidney disease: The Consortium of Radiologic Imaging Studies of Polycystic Kidney Disease CohortJ Am Soc Nephrol20061785486216452494
  • Centers for Disease Control and PreventionPrevalence of Coronary Heart Disease – United States, 2006–2010MMWR Morb Mortal Wkly Rep2011601377141121993341
  • GoASMozaffarianDRogerVLAmerican Heart Association Statistics Committee and Stroke Statistics CommitteeHeart disease and stroke statistics – 2013 update: a report from the American Heart AssociationCirculation2013127e6e24523239837
  • SchillerJSLucasJWWardBWPeregoyJASummary health statistics for US adults: National Health Interview Survey, 2010Vital Health Stat 1020122521207